New Strategies and Molecules Show Promise in Preventing Age-Related Macular Degeneration
A new study suggests that increasing apolipoprotein M (ApoM) levels could slow or prevent age-related macular degeneration (AMD) by improving cholesterol processing in the retina, potentially offering a new treatment to preserve vision and benefit heart health, with promising results in mouse models.
